openPR Logo
Press release

Chronic Disease Management Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share

02-21-2025 07:57 AM CET | IT, New Media & Software

Press release from: The Business Research Company

Chronic Disease Management Market Size

Chronic Disease Management Market Size

Which drivers are expected to have the greatest impact on the over the chronic disease management market's growth?
The escalating number of elderly individuals is notably contributing to the expansion of the chronic disease management market. Elderly populations are those aged 65 and above. This demographic has the greatest risk of being affected by chronic medical conditions. These chronic ailments often entail a heightened demand for medical treatment and consistent long-term care services, necessitating an increase in chronic disease management solutions. For instance, in a report released by the World Health Organization (WHO), a Switzerland-based public health international authority, it was projected that by October 2024, one out of every six people globally would be 60 years or older by 2030. Furthermore, by the year 2050, the global population of individuals aged 60 years or above would reach 2.1 billion. Hence, the burgeoning geriatric population will fuel the growth of the chronic disease management market.

Get Your Chronic Disease Management Market Report Here:
https://www.thebusinessresearchcompany.com/report/chronic-disease-management-global-market-report

What is the future CAGR of the chronic disease management market, and how will it impact industry expansion?
There has been a swift expansion in the market size for chronic disease management in the past few years. The market that was worth $9.55 billion in 2024 is projected to increase to $11.36 billion in 2025, boasting a compound annual growth rate (CAGR) of 19.0%. The remarkable growth in the past can be credited to the implementation of data analytics for managing population health, patient education that encourages empowerment, the introduction of value-based care models, the development of personalized treatment plans, and an emphasis on preventive healthcare.

In the coming years, it is predicted that the chronic disease management market will experience a significant upturn, with a projected growth to $24.97 billion by 2029, boasting a compound annual growth rate (CAGR) of 21.8%. This anticipated surge within the forecast period can be tied back to several factors such as the adoption of patient-centric care structures, the aging of the population, an emphasis on remote patient monitoring (rpm), a rise in chronic disease cases, and predominant healthcare tendencies on a global scale. Key trends that will be prominent during the projection period encompass global health crises and reactions to pandemics, government-led initiatives and policy endorsement, the proliferation of consumer-centric health applications and platforms, health information exchange and interoperability, and an increase in concentration towards behavioral health and telehealth advancements.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6984&type=smp

What are the most significant trends transforming the chronic disease management market today?
The uptake of technological advancements is a significant trend in the chronic disease management market. Innovative solutions such as artificial intelligence (AI) are being incorporated in the treatment of chronic diseases. Through AI usage, healthcare providers can achieve significant developments in early detection and improvement of patient outcomes for conditions such as heart disease, cancer, and diabetes. For example, Biofourmis, a Boston-based company that focuses on AI-based virtual care and digital pharmaceuticals, introduced Bioformis Care in February 2022. This service offers superior remote care for chronic disease patients. The main focus of Biofourmis Care is to enhance adherence to care instructions by providers and identify clinical deterioration patterns to facilitate early intervention.

Which key market segments comprise the chronic disease management market and drive its revenue growth?
The chronic disease management market covered in this report is segmented -

1) By Service: Consulting Service, Implementation Service, Educational Service
2) By Delivery Mode: On-premise, Cloud-based, Web-based
3) By Disease Type: Cardiovascular Diseases, Diabetes, Cancer, Asthma, Chronic Obstructive Pulmonary Disorders
4) By End User: Providers, Payers

Subsegments:
1) By Consulting Service: Disease Management Assessment, Program Design And Development, Performance Evaluation
2) By Implementation Service: Technology Integration, Workflow Optimization, Care Coordination
3) By Educational Service: Patient Education Programs, Provider Training, Community Awareness Initiatives

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6984

What regions are at the forefront of chronic disease management market expansion?
North America was the largest region in the chronic disease management market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic disease management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Who are the leading players fueling growth in the chronic disease management market?
Major companies operating in the chronic disease management market include Allscripts Healthcare Solutions Inc. (now known as Veradigm Inc. ), ScienceSoft USA Corporation, Siemens Healthcare Private Limited, Infosys Limited, MINES and Associates Inc., Biofourmis Care Solutions Pte. Ltd., i2i Systems Inc., Phytel Inc., Wellcentive Inc., TriZetto Corporation, Mediware Human & Social Services Inc., Pegasystems Inc., ZeOmega Inc., Cigniti Technologies Limited, Health Catalyst, Cedar Gate Technologies, Epic Systems Corporation, Hinduja Global Solutions Ltd., NXGN Management LLC, Casenet LLC, ExlServings Holdings Inc., cliexa Inc., Vivify Health Inc., WellSky, Alkeus Pharmaceuticals, Healthy. io, Immunic Inc., GlaxoSmithKline (GSK), GEOVAX INC., Bluebird Bio, Optum Inc., Omada Health

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=6984&type=smp

What Is Covered In The Chronic Disease Management Global Market Report?

•Market Size Forecast: Examine the chronic disease management market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the chronic disease management market for a structured understanding.
•Key Players Overview: Analyze major players in the chronic disease management market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the chronic disease management market.
•Segment Contributions: Evaluate how different segments drive overall growth in the chronic disease management market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the chronic disease management market.
•Industry Challenges: Identify potential risks and obstacles affecting the chronic disease management market.
•Competitive Landscape: Review strategic developments in the chronic disease management market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chronic Disease Management Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share here

News-ID: 3880181 • Views:

More Releases from The Business Research Company

Company Registration Service Market Landscape 2025: Forecast Data and Growth Strategy Insights
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Company Registration Service Market Through 2025? The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecasts, and Growth Drivers
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025? In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market in 2025: Advancement In Digital Insurance Platforms Transforms Small And Medium Enterprises Coverage With Integrated, Data-Driven Solutions
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025? The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due To Rising Environmental Monitoring Requirements: Strengthening the Growth Trajectory of the Combustion Emissions Analyzer Market
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025? In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth

All 5 Releases


More Releases for Disease

Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research. Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight: Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and